Inside USP: USP Metals Testing: A Workshop Report - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Inside USP: USP Metals Testing: A Workshop Report
Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.
Nov 2, 2008
By: Stefan Schuber, PhD, Anthony J. DeStefano, PhD, Roger L. Williams, William F. Koch, Darrell R. Abernethy
Pharmaceutical Technology
Volume 32, Issue 11, pp. 152-153
« Previous
123

References

1. USP 31–NF 26 General Chapter <231>, "Heavy Metals," pp. 133–134.

2. T. Wang et al., "An Atomic Spectroscopic Method as an Alternative to Both USP Heavy Metals <231> and USP Residue on Ignition <281>," Pharm Forum. 29 (4), 1328–1336 (2003).

3. USP Ad Hoc Advisory Panel on Inorganic Impurities and Heavy Metals, "General Chapter on Inorganic Impurities: Heavy Metals," Pharm. Forum. 34 (5), 1345–1348 (2008).

4. D.R. Abernethy et al., "Adulteration of Drugs and Foods: Compendial Approaches to Lowering Risk," Clin. Pharm. Ther., in press (2008).

5. EMEA, Guideline on the Specification Limits for Residues of Metal Catalysts (London, March 2008), available at http://www.emea.europa.eu/, accessed Oct. 6, 2008.

« Previous
123

ADVERTISEMENT

blog comments powered by Disqus
About the Author

Stefan Schuber, PhD

Stefan Schuber, PhD, is director, Corporate Planning, Development, and Communications at the US Pharmacopeia. Articles by Stefan Schuber, PhD

Anthony J. DeStefano, PhD

Anthony J. DeStefano, PhD, is vice-president, general chapters at the United States Pharmacopeial Convention. Articles by Anthony J. DeStefano, PhD

Roger L. Williams

Articles by Roger L. Williams

William F. Koch

William F. Koch, PhD, is chief standards acquisition and metrology officer at the US Pharmacopeia. Articles by William F. Koch

Darrell R. Abernethy


Darrell R. Abernethy, MD, PhD, is chief science officer at the US Pharmacopeia. Articles by Darrell R. Abernethy
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Featured Jobs

More Jobs
Source: Pharmaceutical Technology, 11/2/2008
 Click here